Nora Maureen Rooney

Array ( [id] => 1416646 [patent_doc_number] => 06514713 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Methods of detecting BRCA1 mutations' [patent_app_type] => B1 [patent_app_number] => 09/898698 [patent_app_country] => US [patent_app_date] => 2001-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8957 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514713.pdf [firstpage_image] =>[orig_patent_app_number] => 09898698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5951366 [patent_doc_number] => 20020006653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-17 [patent_title] => '25692, a novel human O-Methyltransferase family member and uses thereof' [patent_app_type] => new [patent_app_number] => 09/844468 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 46682 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20020006653.pdf [firstpage_image] =>[orig_patent_app_number] => 09844468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6519300 [patent_doc_number] => 20020192221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'METHOD FOR TREATING TUMOR USING A COMBINATION OF ENERGY AND ANTIBODY CONJUGATED TOXIN' [patent_app_type] => new [patent_app_number] => 09/838008 [patent_app_country] => US [patent_app_date] => 2001-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9721 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192221.pdf [firstpage_image] =>[orig_patent_app_number] => 09838008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6986628 [patent_doc_number] => 20010036460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Targeted death cancer cells' [patent_app_type] => new [patent_app_number] => 09/828409 [patent_app_country] => US [patent_app_date] => 2001-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4790 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036460.pdf [firstpage_image] =>[orig_patent_app_number] => 09828409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6307888 [patent_doc_number] => 20020094966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => '88kDa tumorigenic growth factor and antagonists' [patent_app_type] => new [patent_app_number] => 09/824807 [patent_app_country] => US [patent_app_date] => 2001-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19013 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094966.pdf [firstpage_image] =>[orig_patent_app_number] => 09824807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1449675 [patent_doc_number] => 06455280 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Methods and compositions for inhibiting neoplastic cell growth' [patent_app_type] => B1 [patent_app_number] => 09/750580 [patent_app_country] => US [patent_app_date] => 2000-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 99752 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455280.pdf [firstpage_image] =>[orig_patent_app_number] => 09750580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1577640 [patent_doc_number] => 06448041 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Colon cancer marker' [patent_app_type] => B1 [patent_app_number] => 09/740235 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23123 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448041.pdf [firstpage_image] =>[orig_patent_app_number] => 09740235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495380 [patent_doc_number] => 06403560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Immunopotentiator and method for preparing the same' [patent_app_type] => B1 [patent_app_number] => 09/685135 [patent_app_country] => US [patent_app_date] => 2000-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 1834 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403560.pdf [firstpage_image] =>[orig_patent_app_number] => 09685135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1269567 [patent_doc_number] => 06653074 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Methods for identifying agents which affect cellular morphology, locomotion and death' [patent_app_type] => B1 [patent_app_number] => 09/669459 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 56 [patent_no_of_words] => 27183 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653074.pdf [firstpage_image] =>[orig_patent_app_number] => 09669459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1574380 [patent_doc_number] => 06468768 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Galectin 9 and 10SV polynucleotides' [patent_app_type] => B1 [patent_app_number] => 09/656450 [patent_app_country] => US [patent_app_date] => 2000-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24930 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468768.pdf [firstpage_image] =>[orig_patent_app_number] => 09656450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1489833 [patent_doc_number] => 06416956 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Transcription factor, BP1' [patent_app_type] => B1 [patent_app_number] => 09/636735 [patent_app_country] => US [patent_app_date] => 2000-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 24126 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/416/06416956.pdf [firstpage_image] =>[orig_patent_app_number] => 09636735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589854 [patent_doc_number] => 06482929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => 'Antibodies to ARF-p19' [patent_app_type] => B1 [patent_app_number] => 09/610833 [patent_app_country] => US [patent_app_date] => 2000-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 21196 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482929.pdf [firstpage_image] =>[orig_patent_app_number] => 09610833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1491198 [patent_doc_number] => 06417332 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Human RCE1' [patent_app_type] => B1 [patent_app_number] => 09/603567 [patent_app_country] => US [patent_app_date] => 2000-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9873 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417332.pdf [firstpage_image] =>[orig_patent_app_number] => 09603567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517944 [patent_doc_number] => 06500932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same' [patent_app_type] => B1 [patent_app_number] => 09/530422 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4612 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500932.pdf [firstpage_image] =>[orig_patent_app_number] => 09530422 [rel_patent_id] =>[rel_patent_doc_number] =>)